Abstract
Human-immunodeficiency-virus (HIV)–based lentiviral vectors are a promising tool for in vivo gene therapy1. Unlike Moloney-murine-leukaemia–based retroviruses (MLV), lentiviruses are believed to stably transduce quiescent (non-cycling) cells in various organs2,3,4,5,6. No previous studies, however, have directly established the cell-cycle status of any transduced cell type at the time of vector administration in vivo. In vitro studies using wild-type HIV or HIV-based vectors have shown that, in some cases, cell-cycle activation is required for infection, even though cellular mitosis is not an absolute requirement for integration7,8,9. Even if the block in reverse transcription is overcome in quiescent T cells, productive infection by HIV cannot be rescued in the absence of cell-cycle activation7,10. The potential use of these vectors for gene therapy prompted our study, which establishes a cell-cycle requirement for efficient transduction of hepatocytes in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Poeschla, E., Corbeau, P. & Wong-Staal, F. Development of HIV vectors for anti-HIV gene therapy . Proc. Natl Acad. Sci. USA 93, 11395– 11399 (1996).
Naldini, L., Blomer, U., Gage, F.H., Trono, D. & Verma, I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. USA 93, 11382 –11388 (1996).
Naldini, L., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267 (1996).
Kafri, T., Blomer, U., Peterson, D.A., Gage, F.H. & Verma, I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. 17, 314–317 ( 1997).
Blomer, U., et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641–6649 (1997).
Miyoshi, H., Takahashi, M., Gage, F.H. & Verma, I.M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl Acad. Sci. USA 94, 10319 –10323 (1997).
Korin, Y.D. & Zack, J.A. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161–3168 (1998).
Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213–222 (1990).
Sutton, R.E., Reitsma, M.J., Uchida, N. & Brown, P.O. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73, 3649–3660 (1999).
Korin, Y.D. & Zack, J.A. Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated Go lymphocytes. J. Virol. 73, 6526–6532 ( 1999).
Kay, M.A. et al. Hepatic gene therapy: persistent expression of human α 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3, 641–647 ( 1992).
Liu, M.L., Winther, B.L. & Kay, M.A. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-moloney murine leukemia virus-derived retrovirus vectors: comparisons of VSV-G and amphotropic vectors for hepatic gene therapy. J. Virol. 70, 2497–2502 (1996).
Branchereau, S., Calise, D. & Ferry, N. Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo. Hum. Gene Ther. 5, 803–808 (1994).
Sakai, H., et al. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 67, 1169–1174 (1993).
Roe, T., Reynolds, T.C., Yu, G. & Brown, P.O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099–2108 (1993).
Lewis, P., Hensel, M. & Emerman, M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053– 3058 (1992).
Andreadis, S.T., Brott, D., Fuller, A.O. & Palsson, B.O. Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 71, 7541–7548 (1997).
Stevenson, M., Stanwick, T.L., Dempsey, M.P. & Lamonica, C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551– 1560 (1990).
Snyder, R.O. et al. Persistence and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270–276 (1997).
Gao, C., et al. Intramuscular injection of an adenoviral vector expressing heaptocyte growth factor facilitates hepatic transduction with a retroviral vector in mice. Hum. Gene Ther. 10, 911– 922 (1999).
Patijn, G.A., Lieber, A., Schowalter, D.B., Schwall, R. & Kay, M.A. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 28, 707– 716 (1998).
Higgins, G.M. & Anderson, R.M. Experimental pathology of the liver: restorarion of the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186– 202 (1931).
Yoshimura, S. & Kamada, N. Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse. Transplant. Proc. 21, 911–912 ( 1989).
Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15 , 871–875 (1997).
Stockschlader, M.A., Storb, R., Osborne, W.R. & Miller, A.D. L-histidinol provides effective selection of retrovirus-vector-transduced kericinocytes without impairing their proliferative potential. Hum. Gene Ther. 2, 33–39 (1991 ).
Dull, T., et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463– 8471 (1998).
Acknowledgements
We thank L. Meuse for handling of the mice. F.P. is a recipient of the Judith Graham Pool Fellowship through the National Hemophilia Foundation. K.O. is a recipient of the Japan Society for the Promotion of Science Fellowship. This work was supported by NIH RO1-HL53682.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, F., Ohashi, K., Chiu, W. et al. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 24, 49–52 (2000). https://doi.org/10.1038/71673
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/71673